Skip to main content
logo
PolyPeptide Group AG (SWX:PPGN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
29.80
+0.10 (0.34%)
Apr 2, 2026, 5:30 PM CET

PolyPeptide Group AG Revenue

In the year 2025, PolyPeptide Group AG had annual revenue of 389.33M EUR with 15.60% growth. PolyPeptide Group AG had revenue of 222.23M in the half year ending December 31, 2025, with 17.87% growth.

Revenue
389.33M EUR
Revenue Growth
+15.60%
P/S Ratio
2.70
Revenue / Employee
270.37K EUR
Employees
1,440
Market Cap
980.29M CHF

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025389.33M52.54M15.60%
Dec 31, 2024336.79M16.42M5.13%
Dec 31, 2023320.37M39.39M14.02%
Dec 31, 2022280.98M-1.15M-0.41%
Dec 31, 2021282.13M57.83M25.78%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Roche Holding AG63.36B
Novartis AG44.94B
Lonza Group AG6.53B
Galderma Group AG4.16B
Aevis Victoria955.96M
SKAN Group AG333.34M
Medartis Holding AG269.26M
Basilea Pharmaceutica AG232.38M
Revenue Rankings

PolyPeptide Group AG News

More News